Introduction {#s2}
============

Allergic rhinitis, allergic dermatitis, and food allergy, in addition to asthma, are extremely common diseases worldwide. Indeed, allergic rhinitis affects 10% to 20% of the general population in Europe and the US [@pmed.1001611-Ozdoganoglu1],[@pmed.1001611-Bauchau1] and up to 40% of children [@pmed.1001611-Berger1]. The prevalence of allergy to any food varies between 3% and 35% [@pmed.1001611-Rona1], while that of allergic dermatitis reaches 20% in many countries [@pmed.1001611-DaVeiga1]. These diseases have profound consequences on the patient\'s quality of life and imply a high cost both to the patient and insurance providers [@pmed.1001611-Meltzer1],[@pmed.1001611-Nathan1]. Among infants, these costs reach more than US\$4,000 per year per case of food allergy [@pmed.1001611-Alanne1].

Recent studies have suggested that these diseases are but one unique set of immunoglobulin-E (IgE)-mediated allergic conditions, linked by the common thread of "atopic march" [@pmed.1001611-Spergel1]. This concept postulates that those conditions are a continuous state that starts with dermatitis and food allergy and eventually progresses to asthma and allergic rhinitis. Indeed, these diseases often co-exist in the same patient and can predict the occurrence of each other [@pmed.1001611-Tan1].

Worldwide, the prevalence of allergic diseases has increased substantially in the last few decades [@pmed.1001611-Asher1],[@pmed.1001611-Ghouri1], which may have two explanations. On the one hand, increased clinician awareness, as well as patient and parental awareness, may have led to improved identification and increased case presentation to physicians [@pmed.1001611-Ghouri1]. On the other hand, it is possible that this increase is due to changing exposure to known and unknown risk factors [@pmed.1001611-Mosges1], and among these factors, smoking may play a role. An increased risk of allergic diseases among individuals exposed to tobacco smoke is biologically plausible as smoking is known to facilitate sensitization to perennial indoor allergens, such as those caused by furry animals, as well as to some outdoor allergens such as pollen [@pmed.1001611-Lanner1].

Increased risk of food allergy among infants exposed to tobacco smoke is also plausible. Food allergens are likely to be found in house dust. Swallowed foods are also inhaled or aspirated by infants, and thus, may cause sensitization that could be facilitated by exposure to tobacco smoke. The early and simultaneous exposure to tobacco smoke and food allergens may interfere with the normal development of immunologic tolerance and thus, facilitate sensitization to food [@pmed.1001611-Lanner1].

Furthermore, smoking augments nasal responses to allergen in atopic subjects and increases IgE, immunoglobulin G4 (IgG4), and postallergen histamine levels in nasal lavage fluid [@pmed.1001611-DiazSanchez1],[@pmed.1001611-Peden1].

Allergic conditions are, in general, more prevalent in children. A potential effect of smoking would have a considerable impact on public health due to the frequency of exposure worldwide. Indeed, children and adolescents are exposed to secondhand smoke in a proportion that varies between 27.6% in Africa and 77.8% in Europe [@pmed.1001611-Warren1] and approximately 14% of all children were exposed to maternal smoking during pregnancy [@pmed.1001611-Murin1].

Several studies have assessed the association between smoking exposure and allergic diseases. In each of the allergic conditions, results were conflicting and alternated between the harmful effects of smoking [@pmed.1001611-Lanner1],[@pmed.1001611-Cakir1],[@pmed.1001611-Lee1] and protection [@pmed.1001611-Bendtsen1]--[@pmed.1001611-Metsl1], while some studies could not find evidence of any effect [@pmed.1001611-McKeever1]--[@pmed.1001611-Tariq1].

Except for a systematic review and meta-analysis examining the relationship between smoking and asthma in children [@pmed.1001611-Burke1], to our knowledge, there is no comprehensive meta-analysis that examines the evidence for a relationship between smoking and allergic conditions. We, therefore, summarized the scientific evidence and carried out a meta-analysis on exposure to active and passive smoking and the risk of allergic rhinitis, allergic dermatitis, and food allergy among adults and children/adolescents.

Methods {#s3}
=======

Data Sources and Searches {#s3a}
-------------------------

We searched databases from 1966 to June 30th, 2013, to identify all potentially eligible studies. For Medline, we applied the following algorithm both in medical subject heading and in free text words: ("SEASONAL ALLERGIC RHINITIS" OR "POLLEN ALLERG\*" OR "POLLINOSIS" OR "POLLINOSES" OR "HAY FEVER" OR "RHINITIS, ALLERGIC, NONSEASONAL" OR "RHINITIS, ALLERGIC, PERENNIAL" OR "DERMATITIS, ATOPIC" OR ECZEMA OR "FOOD ALLERGIES" OR "HYPERSENSITIVITY, FOOD") AND (SMOKING OR TOBACCO OR CIGARETT\*). We used similar strategies to search Embase and the five regional bibliographic databases of the World Health Organization (AIM, LILACS, IMEMR, IMSEAR, WPRIM). We searched meeting abstracts using the ISI Proceedings database from its inception in 1990 to 2013. We also examined the references of every article retrieved and those of recent reviews of allergic rhinitis and smoking [@pmed.1001611-Peden1],[@pmed.1001611-BaenaCagnani1]--[@pmed.1001611-National1] and established personal contact with clinical researchers to trace further publications or reports. We considered including any relevant article, independently of the language of publication.

Study Selection {#s3b}
---------------

Studies were included if: (1) they presented original data from cohort, case-control, or cross-sectional studies (ecologic studies were not included); (2) the outcome of interest was clearly defined as allergic rhinitis, allergic dermatitis, or food allergy; (3) one of the exposure factors was smoking, either by the subjects themselves or their relatives; (4) they provided estimates of odds ratio (OR), relative risk (RR), or prevalence odds ratio and their confidence intervals, or enough data to calculate them. If data on the same population were duplicated in more than one study, the most recent study was included in the analysis. When data for different types or levels of exposure were available in the same study, such as passive smoking, active smoking, or maternal smoking during pregnancy, we considered each type of exposure separately. We developed a standard data-recording form in which we recorded authors, year of publication, study location, sample size, outcome, outcome measurement details, effect estimator (OR, RR, other), effect estimate, 95% CIs, adjustment factors used, and study design including if the International Study of Asthma and Allergies in Childhood (ISAAC) methodology was followed. ISAAC is a large international epidemiologic study on risk factors of allergic diseases, the methods of which are widely used. When further clarification was necessary, we attempted to contact the authors. Abstracts were reviewed independently by two authors (BT and JS).

Quality Assessment {#s3c}
------------------

Study quality was assessed using a five-point binary scale specifically developed for this study. The scale is based on the Newcastle-Ottawa scale [@pmed.1001611-Wells1] with modifications in view of standard guidelines and our own judgment. The Newcastle-Ottawa scale is a scoring system that assesses every aspect of an observational epidemiologic study from a methodological point of view. For this meta-analysis, we tried to use those elements that were common to all epidemiologic designs and thus shortened the scale considerably. We used the following criteria labelled as "yes" or "no": (1) whether assessment of the smoking habit included duration and/or quantity (yes) or not (no); (2) whether rhinitis diagnosis included clinical features and IgE or skin prick test (SPT) measurements (yes) or was based on clinical examination or questionnaire only (no), whether dermatitis diagnosis included clinically assessed diagnosis (yes) or was based on questionnaire information only (no), whether the diagnosis of food allergy was based on clinical diagnosis with SPT, IgE, or open-challenge test (yes) or was based on questionnaire information only (no); (3) whether results were adjusted for age, sex, and at least one other potential confounder (yes) or not (no); (4) whether participation exceeded 80% of the people initially approached (yes) or not (no); and, finally (5) whether the target population was clearly defined (yes) or, on the contrary, based on convenience sampling of subjects such as patients of a single consultation (no). Throughout this assessment, when the information on a specific item was not provided by the authors, we graded this item as "no." We carried out a pooled analysis on those studies that fulfilled at least three criteria and compared with those that scored fewer than three. As a secondary analysis, we stratified our results on criterion 1 and present the pooled relative risks in [Table S2](#pmed.1001611.s002){ref-type="supplementary-material"}.

Data extraction and quality scoring were performed independently by two reviewers (BT and JS) and the results were merged by consensus. The complete protocol and results for quality scoring are available in [Table S1](#pmed.1001611.s001){ref-type="supplementary-material"}.

Data Synthesis and Analysis {#s3d}
---------------------------

We weighted the study-specific log odds ratios for case control and cross-sectional studies, and log relative risks for cohort studies by the inverse of their variance to compute a pooled relative risk and its 95% confidence interval. For each study, we used the estimate of the effect measure that was adjusted for the largest number of confounders. We present both fixed-effects and random effects pooled estimates but use the latter when heterogeneity was present. Odds ratios from case-control studies were assumed to be unbiased estimates of the relative risk [@pmed.1001611-Rothman1].

We used a version adapted to small samples of the DerSimonian and Laird Q test to check for heterogeneity [@pmed.1001611-Takkouche1]. The null hypothesis of this test is the absence of heterogeneity. To quantify this heterogeneity we calculated the proportion of the total variance due to between-study variance (Ri statistic) [@pmed.1001611-Takkouche1]. Furthermore, we explored the origin of heterogeneity by restricting the analysis to subgroups of studies defined by study characteristics such as study design, type of exposure (active or passive smoking), and age of the participants (children/adolescents or adults).

To check whether the pooled estimates were significantly different between subgroups we carried out a meta-regression with the global effect as dependent variable and the subgroup variable as moderator.

We assessed publication bias, first visually, using funnel plots and then, more formally, using the test proposed by Egger and colleagues [@pmed.1001611-Egger1]. We also used the trim-and-fill method to correct for potential publication bias. All analyses were performed with the software HEpiMA version 2.1.3 [@pmed.1001611-CostaBouzas1] and STATA version 12 with its macros metabias, metareg, and metatrim.

The secondary analyses (children and adolescents/adults, ISAAC/other, cohort and case-control studies combined/cross-sectional studies, high quality/low quality) were planned a priori.

Results {#s4}
=======

We identified 196 studies, published in 139 different articles and carried out in 51 countries, on active or passive smoking and allergic diseases that met our inclusion criteria ([Figure 1](#pmed-1001611-g001){ref-type="fig"}). The data from one study were obtained from the authors [@pmed.1001611-Ozasa1]. We found 97 studies on allergic rhinitis [@pmed.1001611-Cakir1],[@pmed.1001611-Bendtsen1],[@pmed.1001611-McKeever1],[@pmed.1001611-Ozasa1]--[@pmed.1001611-Mitchell1], [@pmed.1001611-Miyake3] on allergic dermatitis [@pmed.1001611-Cakir1],[@pmed.1001611-Lee1],[@pmed.1001611-Ludvigsson1],[@pmed.1001611-McKeever1]--[@pmed.1001611-Tariq1],[@pmed.1001611-Lewis1]--[@pmed.1001611-Bergmann1],[@pmed.1001611-Magnusson1],[@pmed.1001611-Bakke1],[@pmed.1001611-Austin1]--[@pmed.1001611-Duhme1],[@pmed.1001611-Dotterud1],[@pmed.1001611-Hjern1],[@pmed.1001611-Simpson1],[@pmed.1001611-Dotterud2],[@pmed.1001611-Lee2],[@pmed.1001611-Lee3]--[@pmed.1001611-AnnesiMaesano2],[@pmed.1001611-Miyake3],[@pmed.1001611-Obihara1],[@pmed.1001611-Kurosaka1],[@pmed.1001611-Sakar1],[@pmed.1001611-Horak1],[@pmed.1001611-Tanaka1]--[@pmed.1001611-Foliaki1],[@pmed.1001611-Kabir1]--[@pmed.1001611-Musharrafieh1],[@pmed.1001611-Wang2],[@pmed.1001611-Vlaski1],[@pmed.1001611-Tanaka2]--[@pmed.1001611-Rnmark1], and eight on food allergies [@pmed.1001611-Lanner1],[@pmed.1001611-Metsl1],[@pmed.1001611-Tariq1],[@pmed.1001611-Hjern1],[@pmed.1001611-Zeiger1],[@pmed.1001611-Jedrychowski1],[@pmed.1001611-Kavalinas1]--[@pmed.1001611-Dubakien1].

![Flow diagram for study selection.](pmed.1001611.g001){#pmed-1001611-g001}

A large majority of the articles retrieved initially were excluded either because they did not provide any effect measure or the outcome was allergy at large. More specifically, of the studies that could have been relevant to our meta-analysis but were finally excluded, eight were discarded because they were an early version of cohort studies updated in subsequent publications [@pmed.1001611-Taylor1]--[@pmed.1001611-Wang3]. Other studies published their results several times [@pmed.1001611-DeiCas2]--[@pmed.1001611-Thyssen2] in which case we chose to include the most complete report. Some studies were excluded because the outcome was not allergic rhinitis, dermatitis, or food allergy but rather SPT or IgE concentrations [@pmed.1001611-Barbee1]--[@pmed.1001611-HarrisRoberts1]. We also excluded nine studies that used either unspecific outcomes such as nasal symptoms [@pmed.1001611-Tsunoda1],[@pmed.1001611-Jeebhay1], or a mixture of allergic diseases as a single outcome [@pmed.1001611-Angioni1]--[@pmed.1001611-Huang1]. Eight studies [@pmed.1001611-Volkmer1],[@pmed.1001611-Pegas1]--[@pmed.1001611-Dubakiene1] were excluded as they did not present any effect measure. Finally, one ecologic study was not considered further [@pmed.1001611-Mitchell2].

Globally, heterogeneity was substantial overall and similarly high after stratification by design, quality features (including adjustment for confounders), and study population. Given the substantial heterogeneity, we focused on the random effects analyses; however, the fixed effects analyses are presented for comparison and only discussed where they differ.

Allergic Rhinitis {#s4a}
-----------------

Thirty-four studies on active smoking and 63 studies on passive smoking were available ([Figures 2](#pmed-1001611-g002){ref-type="fig"} and [3](#pmed-1001611-g003){ref-type="fig"}; [Tables 1](#pmed-1001611-t001){ref-type="table"} and [2](#pmed-1001611-t002){ref-type="table"}). The overwhelming majority of the studies assessed diagnosis through questionnaire and only seven studies used SPT or IgE measurements for the case definition [@pmed.1001611-Ozasa1],[@pmed.1001611-Wright1],[@pmed.1001611-Bergmann1],[@pmed.1001611-Codispoti1],[@pmed.1001611-Wthrich1],[@pmed.1001611-Tanaka1],[@pmed.1001611-Hkansson1]. The study by Wright and colleagues [@pmed.1001611-Wright1] measured SPT reactivity but used a definition of physician diagnosed allergic rhinitis that included both SPT-positive and SPT-negative children. More than half of the studies used ISAAC criteria for the definition of allergic rhinitis. Finally, 11 studies assessed maternal smoking during pregnancy [@pmed.1001611-Lewis1],[@pmed.1001611-Shaheen1],[@pmed.1001611-Tariq2]--[@pmed.1001611-Johansson1],[@pmed.1001611-Austin1],[@pmed.1001611-Zacharasiewicz1],[@pmed.1001611-BarrazaVillarreal1],[@pmed.1001611-Obihara1],[@pmed.1001611-Horak1],[@pmed.1001611-Chen1].

![Study-specific and random effects pooled relative risks of active smoking and allergic rhinitis.](pmed.1001611.g002){#pmed-1001611-g002}

![Study-specific and random effects pooled relative risks of passive smoking and allergic rhinitis.](pmed.1001611.g003){#pmed-1001611-g003}
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###### Relative risks and 95% confidence intervals of allergic rhinitis by smoking exposure in case-control and cohort studies.

![](pmed.1001611.t001){#pmed-1001611-t001-1}

  Source                                                Country       Population       Follow-up (y)   Complete Follow-up (%)    Active Smoking      Passive Smoking    Cases/Controls or Cohort Size                                  Variables of Adjustment, Matching, or Restriction
  ---------------------------------------------------- --------- -------------------- --------------- ------------------------ ------------------- ------------------- ------------------------------- -----------------------------------------------------------------------------------------------------------------
  **Case-control studies**                                                                                                                                                                             
  Ozasa 1995 [@pmed.1001611-Ozasa1]                      Japan          Adults              ---                 ---             0.38 (0.19--0.76)   0.45 (0.31--0.65)               89/89                                                                     Age
  Cakir 2010 [@pmed.1001611-Cakir1]                     Turkey       Adolescents            ---                 ---             1.57 (1.16--2.11)   1.61 (1.17--2.21)              436/366                                             Age, sex, family atopy, pets, income, occupation
  Lin 2011 [@pmed.1001611-Lin1]                           USA           Adults              ---                 ---                    ---          2.05 (1.34--3.15)              83/117                                                             Age, sex, education
  Miyake 2011 [@pmed.1001611-Miyake1]                    Japan       Adult women            ---                 ---             1.13 (0.86--1.48)          ---                     393/767                                                                    Sex
  **Cohort studies**                                                                                                                                                                                   
  Wright 1994 [@pmed.1001611-Wright1]                     USA          Children              6                  76.8                   ---          1.93 (1.63--2.30)              311/747                                                               Not specified
  Annesi-Maesano 1997 [@pmed.1001611-AnnesiMaesano1]    France        Adult men              5                   49             1.75 (1.15--2.68)          ---                     126/191                                                                    Sex
  Lewis 1998 [@pmed.1001611-Lewis1]                       UK           Children             16                   55                    ---          0.89 (0.82--0.97)            1,646/6,281                    Age, sex, social class, low birth weight, gestational age, breast feeding, maternal age, parity
  Shaheen 1999 [@pmed.1001611-Shaheen1]                   UK         Young adults           26                  51.1            0.91 (0.83--1.00)          ---                     ?/6,420                            Age, sex, birth weight, social class, siblings, education, height, body mass index
  Bergmann 2000 [@pmed.1001611-Bergmann1]               Germany        Children              6                   75                    ---          1.05 (0.72--1.55)              178/825              Age, sex, parental atopy, socioeconomic status, breast feeding, aeroallergen and food sensitivity, study center
  Tariq 2000 [@pmed.1001611-Tariq2]                       UK           Children              4                  79.3                   ---          0.88 (0.47--1.65)              65/1218                                                                    Age
  McKeever 2001 [@pmed.1001611-McKeever1]                 UK           Children             11                   95                    ---          1.02 (0.94--1.11)           1,113/29,238                                                   Age, sex, family atopy, siblings
  Magnusson 2005 [@pmed.1001611-Magnusson1]             Denmark        Children             18                   74                    ---           1.1 (1.0--1.4)              1,083/7,844                  Sex, social class, occupation, maternal age in pregnancy, coffee consumption, parity, breastfeeding
  Johansson 2008 [@pmed.1001611-Johansson1]             Sweden         Children              3                  51.9                   ---          1.20 (1.10--1.31)              ?/8,850                                                   Age, mothers\' education, family type
  Nagata 2008 [@pmed.1001611-Nagata1]                    Japan          Adults              10                  81.6            0.76 (0.66--0.89)          ---                  1,000/12,221                                Age, sex, marital status, education, body mass index, farming, alcohol
  Bendtsen 2008 [@pmed.1001611-Bendtsen1]               Denmark      Adult women             9                   87             0.84 (0.76--0.94)          ---                   1,354/5,870                                             Age, sex, education, alcohol, parental asthma
  Keil 2009 [@pmed.1001611-Keil1]                       Germany        Children             10                   73                    ---          1.03 (0.74--1.44)              198/784                         Age, sex, birth weight, breast feeding, siblings, pets, parental education, IgE, location
  Codispoti 2010 [@pmed.1001611-Codispoti1]               USA     High risk children         2                   ?                     ---          1.29 (0.74--2.25)              116/361                                                          Age, parental allergies

10.1371/journal.pmed.1001611.t002

###### Relative risks and 95% confidence intervals of allergic rhinitis by smoking exposure in cross-sectional studies.

![](pmed.1001611.t002){#pmed-1001611-t002-2}

  Source                                                                         Country                Population           Active Smoking      Passive Smoking    Study Size                                                        Variables of Adjustment, Matching, or Restriction
  ------------------------------------------------------------------------ -------------------- -------------------------- ------------------- ------------------- ------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bakke 1990 [@pmed.1001611-Bakke1]                                               Norway          Adolescents and adults    0.68 (0.58--0.80)          ---            4,270                                                               Age, sex, occupational exposure, residence
  Leuenberger 1994 [@pmed.1001611-Leuenberger1]                                Switzerland                Adults                   ---          1.02 (0.82--1.28)     3,494                                                                             Not specified
  Ng 1994 [@pmed.1001611-Ng1]                                                   Singapore                 Adults            1.16 (0.82--1.65)          ---            2,868                                                           Age, race, housing, cockroaches, occupation, fumes
  Moyes 1995 [@pmed.1001611-Moyes1]                                            New Zealand            Schoolchildren               ---          0.80 (0.55--1.15)     5,360                                                                                  Age
  Wutrich 1996 [@pmed.1001611-Wthrich1]                                        Switzerland                Adults            0.62 (0.53--0.71)          ---            8,344                                                                           Age, sex, location
  Min 1997 [@pmed.1001611-Min1]                                                   Korea            Children and adults      0.81 (0.38--1.34)          ---            8,853                                                                                  Age
  Siracusa 1997 [@pmed.1001611-Siracusa1]                                         Italy            Children and adults       0.9 (0.5--1.9)            ---             824                                                                           Age, sex, allergens
  Austin 1997 [@pmed.1001611-Austin1]                                               UK                   Children                  ---          0.63 (0.51--0.77)     1,537                                                                                  Age
  Farooqi 1998 [@pmed.1001611-Farooqi1]                                             UK                   Children                  ---          1.04 (0.82--1.32)     1,934                                                                             Not specified
  Lam 1998 [@pmed.1001611-Lam1]                                                 Hong Kong             Schoolchildren        0.97 (0.86--1.09)   0.98 (0.86--1.12)     6,304                                                                      Age, sex, residence, housing
  Ponsonby 1998 [@pmed.1001611-Ponsonby1]                                       Australia                Children                  ---          0.95 (0.86--1.05)     6,378                                                                                  Age
  Montefort 1998 [@pmed.1001611-Montefort1]                                       Malta               Schoolchildren        1.67 (1.43--1.95)   1.13 (1.0--1.28)      4,184                                                             Age, sex, road, pets, parental atopy, blankets
  Duhme 1998 [@pmed.1001611-Duhme1]                                              Germany              Schoolchildren        1.37 (1.17--1.59)   1.01 (0.90--1.13)     13,123                                                                               Age, sex
  Burr 1999 [@pmed.1001611-Burr1]                                                   UK                Schoolchildren        1.30 (1.23--1.36)   1.04 (1.00--1.09)     25,393                                                Age, sex, location, residence, pets, cooking and heating fuel, housing
  Dotterud 1999 [@pmed.1001611-Dotterud1]                                         Russia                  Adults            0.69 (0.40--1.17)          ---            3,368                                                                             Not specified
  Keles 1999 [@pmed.1001611-Kele1]                                                Turkey               Adolescents           0.6 (0.2--1.6)      0.8 (0.4--1.3)        386                                                                       Age, sex, heating, location
  Plaschke 2000 [@pmed.1001611-Plaschke1]                                         Sweden                  Adults            0.82 (0.49--1.37)          ---            1,370                                                                  Age, sex, location, pets, allergens
  Zacharasiewicz 2000 [@pmed.1001611-Zacharasiewicz1]                            Austria                 Children                  ---          1.04 (0.93--1.17)     18,606                                                           Age, sex, family history of hay fever, education
  Upton 2000 [@pmed.1001611-Upton1]                                                 UK                    Adults            0.70 (0.54--0.91)          ---            2,832                                                                                  Age
  Ozdemir 2000 [@pmed.1001611-Ozdemir1]                                           Turkey           University freshmen      1.28 (0.82--1.98)          ---            1,515                                                                                  Age
  Hjern 2001 [@pmed.1001611-Hjern1]                                               Sweden                 Children                  ---          0.96 (0.83--1.12)     4,472                           Age, sex, siblings, parental education, residence, single parent household, country of birth of parents, location
  Hjern 2001 [@pmed.1001611-Hjern1]                                               Sweden                  Adults            0.78 (0.72--0.84)          ---            6,909                                                       Age, sex, education, residence, country of birth, location
  Janson 2001 [@pmed.1001611-Janson1]                                             World                   Adults                   ---          1.02 (0.81--1.20)     7,882                                                                   Age, sex, allergens, IgE, location
  Simpson 2001 [@pmed.1001611-Simpson1]                                             UK                    Adults            0.78 (0.65--0.93)          ---            5,687                                                                          Sex, allergens, pets
  Dotterud 2001 [@pmed.1001611-Dotterud2]                                         Russia              Schoolchildren              -----         0.90 (0.69--1.17)     1,684                                                            Age, sex, carpets, dampness, pets, heating type
  Kalyoncu 2001 [@pmed.1001611-Kalyoncu1]                                         Turkey           University students      1.24 (1.01--1.53)   1.20 (1.06--1.35)     4,639                                                          Age, sex, region, family atopy, pets, elder siblings
  Lee 2001 [@pmed.1001611-Lee2]                                                   Korea               Schoolchildren               ---          1.19 (1.11--1.28)     38,955                                                      Age, sex, region, body mass index, carpets, pets, location
  Stazi 2002 [@pmed.1001611-Stazi1]                                               Italy                  Children                  ---           2.2 (1.2--4.1)        201                                                                                 Age, sex
  Peroni 2003 [@pmed.1001611-Peroni1]                                             Italy             Preschool children             ---          1.19 (0.89--1.59)     1,402                                                                                  Age
  Barraza 2003 [@pmed.1001611-BarrazaVillarreal1]                                 Mexico              Schoolchildren               ---          1.37 (1.23--1.52)     6,174                                   Age, school, cockroaches, respiratory problems, use of carpets, humidity, family history of asthma
  Monteil 2004 [@pmed.1001611-Monteil1]                                     Trinidad & Tobago         Schoolchildren               ---          1.41 (1.26--1.59)     3,170                                                                                  Age
  Lee 2004 [@pmed.1001611-Lee3]                                                 Hong Kong            School children               ---          0.81 (0.72--0.91)     4,448                                   Age, sex, birth weight, siblings, respiratory tract infections, parental atopy, pets, study period
  Kramer 2004 [@pmed.1001611-Krmer1]                                             Germany             School beginners              ---          0.86 (0.38--1.96)     1,220                                                                      Age, sex, atopy, nationality
  Demir 2004 [@pmed.1001611-Demir1]                                               Turkey              Schoolchildren               ---          2.43 (1.32--4.52)     1,064                                                                                  Age
  Miyake 2004 [@pmed.1001611-Miyake2]                                             Japan               Schoolchildren               ---          1.11 (0.98--1.27)     5,539                                 Age, sex, grade, older siblings, maternal age at child birth, pets, history of other allergic diseases
  Annesi-Maesano 2004 [@pmed.1001611-AnnesiMaesano2]                              France               Adolescents          1.65 (1.48--1.84)   1.15 (1.09--1.22)     14,578                                                                               Age, sex
  De 2005 [@pmed.1001611-De1]                                                    Ireland                 Children                  ---          1.16 (0.43--3.12)       81                                                                              Not specified
  Topp 2005 [@pmed.1001611-Topp1]                                                Germany                  Adults                   ---          1.10 (0.93--1.30)     4,093                                                                    Age, sex, social class, location
  Maziak 2005 [@pmed.1001611-Maziak1]                                             Syria                   Adults                   ---          1.12 (0.85--1.48)     1,118                                                      Age, sex, familial atopy, socioeconomic status, occupational
  Miyake 2005 [@pmed.1001611-Miyake3]                                             Japan               Pregnant women        1.10 (0.85--1.42)   1.33 (1.09--1.62)     1,002                                    Age, sex, familial atopy, pets, gestation, parity, family income, education, mite antigen level
  Bugiani 2005 [@pmed.1001611-Bugiani1]                                           Italy                Young adults         0.76 (0.69--0.84)          ---            17,666                                                                            Not specified
  Obihara 2005 [@pmed.1001611-Obihara1] [a](#nt101){ref-type="table-fn"}       South Africa              Children                  ---                 ---             861                                          Age, sex, maternal atopy, breast feeding, siblings, household income, tuberculin test
  Strumylaite 2005 [@pmed.1001611-Strumylaite1]                                 Lithuania                Children                  ---          0.85 (0.20--3.45)      594                                                                                   Age
  Lund 2006 [@pmed.1001611-Lund1] [b](#nt102){ref-type="table-fn"}                France               Mature women         1.10 (0.92--1.30)    1.31 (1.0--1.6)      2,197                                                                                Age, sex
  Kurosaka 2006 [@pmed.1001611-Kurosaka1]                                         Japan               Schoolchildren               ---          0.82 (0.78--0.87)     35,213                                                                            Age, sex, pets
  Sakar 2006 [@pmed.1001611-Sakar1]                                               Turkey                  Adults            1.30 (0.99--1.71)   1.33 (0.96--1.83)     1,336                                                                         Age, sex, family atopy
  Ho 2007 [@pmed.1001611-Ho1]                                                   Hong Kong                 Adults                   ---          1.34 (0.93--1.94)      200                                                               Age, sex, education, occupational exposures
  Horak 2007 [@pmed.1001611-Horak1]                                              Austria            Preschool children             ---          1.31 (0.90--1.90)     1,737                                        Age, sex, familial atopy, education, family size, pets, breastfeeding, healthy nutrition
  Ebbert 2007 [@pmed.1001611-Ebbert1]                                              USA                    Adults                   ---          1.16 (0.85--1.59)     1,007                                                                             Not specified
  Tanaka 2007 [@pmed.1001611-Tanaka1]                                             Japan                  Children                  ---          1.07 (0.98--1.16)     23,044                                                    Age, sex, location, familial atopy, siblings, education level
  Zuraimi 2008 [@pmed.1001611-Zuraimi1]                                         Singapore           Preschool children             ---          1.22 (1.11--1.35)     4,759      Age, sex, familial atopy, race, socioeconomic status, housing type, breastfeeding, food allergy, respiratory infections, housing conditions, traffic density
  Foliaki 2008 [@pmed.1001611-Foliaki1]                                     Pacific countries            Children                  ---          1.05 (0.99--1.12)     17,683                                                                          Age, sex, country
  Gomez 2008 [@pmed.1001611-Gmez1]                                              Argentina              Adolescents          1.72 (1.48--1.99)          ---            3,000                                                                                  Age
  Kabir 2009 [@pmed.1001611-Kabir1]                                              Ireland                 Children                               1.30 (1.01--1.67)     2,809                                                                                Age, sex
  Brescianini 2009 [@pmed.1001611-Brescianini1]                                   Italy               Schoolchildren               ---          1.17 (0.79--1.76)      481                                             Age, sex, family atopy, body mass index, pets, physical activity, diet, location
  Musharrafieh 2009 [@pmed.1001611-Musharrafieh1]                                Lebanon               Adolescents                 ---           1.0 (0.8--1.2)       3,115                                                          Age, sex, nationality, regions, school type, traffic
  Gonzalez-Diaz 2010 [@pmed.1001611-GonzlezDaz1]                                  Mexico         Children and Adolescents          ---          1.37 (1.23--1.53)     23,191                                                                                 Age
  Bedolla-Barajas 2010 [@pmed.1001611-BedollaBarajas1]                            Mexico              Schoolchildren               ---          1.01 (0.48--2.13)      740                                                                                   Age
  Wang 2010 [@pmed.1001611-Wang2]                                                 Canada              Schoolchildren               ---          1.00 (0.81--1.24)     8,334               Age, sex, body mass index, location, birthplace, ethnicity, maternal education, siblings, fuel use, pets, acetaminophen, physical activity
  Vlaski 2011 [@pmed.1001611-Vlaski1]                                           Macedonia              Adolescents               **---**        0.99 (0.88--1.11)     3,026                                            Age, sex, diet, type of cooking and heating, pets, maternal education, siblings
  Virkkula 2011 [@pmed.1001611-Virkkula1]                                        Finland                 Children                  ---          2.29 (1.07--4.87)       38                                                                                   Age
  Hakansson 2011 [@pmed.1001611-Hkansson1]                                       Denmark                  Adults            0.79 (0.68--0.92)          ---            3,471                                                                                Age, sex
  Chen 2012 [@pmed.1001611-Chen1]                                                 Taiwan                 Children                  ---                 ---            4,221                                                              Age, sex, parental atopy, parental education
  Peñaranda 2012 [@pmed.1001611-Pearanda1]                                       Colombia                Children                  ---          1.19 (0.99--1.42)     3,256                                 Age, asthma, dermatitis, use of acetaminophen and antibiotics, maternal education, caesarean delivery
  Peñaranda 2012 [@pmed.1001611-Pearanda1]                                       Colombia              Adolescents           1.4 (1.2--1.7)            ---            3,829                                             Age, asthma, dermatitis, use of acetaminophen, consumption of fast-food, cats
  Tanaka 2012 [@pmed.1001611-Tanaka2]                                             Japan               Pregnant women        1.01 (0.84--1.23)   1.50 (1.14--1.96)     1,743                                               Age, sex, region of residence, parental atopy, household income, education
  Montefort 2012 [@pmed.1001611-Montefort2]                                       Malta                  Children           1.40 (1.11--1.76)   1.11 (1.02--1.20)     7,955                                                                                  Age
  Mitchell 2012 [@pmed.1001611-Mitchell1]                                   Multiple countries           Children                  ---          1.10 (1.08--1.12)    573,061                                                          Age, sex, language, region, gross national income

Only data on maternal smoking during pregnancy are available.

This study used cases of rhinitis at large, not only allergic rhinitis.

[Table 3](#pmed-1001611-t003){ref-type="table"} shows the results for associations between smoking and allergic rhinitis.

10.1371/journal.pmed.1001611.t003

###### Pooled relative risks and 95% confidence intervals of allergic rhinitis and smoking.

![](pmed.1001611.t003){#pmed-1001611-t003-3}

  Study Type                     Number of Studies   RR (95% CI) Fixed Effects   RR (95% CI) Random Effects   Ri[a](#nt103){ref-type="table-fn"} (95% CI)   Q test (*p*-Value)
  ----------------------------- ------------------- --------------------------- ---------------------------- --------------------------------------------- --------------------
  **Active smoking**                                                                                                                                       
  All studies                           34               1.06 (1.03--1.08)           1.02 (0.92--1.15)                     0.95 (0.90--0.99)                     0.00001
  Cohort studies                         4               0.87 (0.82--0.93)           0.91 (0.77--1.07)                     0.82 (0.47--1.00)                      0.0024
  Case-control studies                   3               1.19 (0.99--1.45)           0.97 (0.55--1.70)                     0.88 (0.59--1.00)                      0.0009
  Cross-sectional studies               27               1.09 (1.06--1.12)           1.03 (0.91--1.18)                     0.95 (0.91--1.00)                     0.00001
  Cohort+case-control studies            7               0.90 (0.85--0.96)           0.98 (0.81--1.18)                     0.87 (0.66--1.00)                     0.00001
  Full adjustment                       18               1.07 (1.04--1.10)           1.02 (0.88--1.20)                     0.96 (0.92--1.00)                     0.00001
  Incomplete adjustment                 16               1.03 (0.98--1.08)           1.02 (0.86--1.22)                     0.91 (0.83--0.99)                     0.00001
  Adults only                           21              0.84 (0. 81--0.87)           0.90 (0.82--0.99)                     0.82 (0.66--0.97)                     0.00001
  Children/adolescents only             10               1.35 (1.30--1.39)           1.40 (1.24--1.59)                     0.90 (0.77--1.00)                     0.00001
  Children ISAAC method                  8               1.39 (1.34--1.44)           1.50 (1.35--1.66)                     0.85 (0.63--1.00)                     0.00001
  Children non-ISAAC method              2               0.96 (0.86--1.08)           0.96 (0.86--1.08)                     0.00 (0.00--1.00)                       0.34
  Quality score ≥3                      15               0.89 (0.86--0.93)           0.95 (0.85--1.06)                     0.86 (0.73--0.99)                     0.00001
  Quality score \<3                     19               1.19 (1.16--1.23)           1.09 (0.92--1.29)                     0.96 (0.91--1.00)                     0.00001
  Passive Smoking                                                                                                                                          
  All studies                           63               1.08 (1.07--1.10)           1.10 (1.06--1.15)                     0.87 (0.75--0.99)                     0.00001
  Cohort studies                         9               1.08 (1.03--1.13)           1.14 (0.96--1.34)                     0.90 (0.76--1.00)                     0.00001
  Case-control studies                   3               1.13 (0.91--1.39)           1.14 (0.46--2.82)                     0.95 (0.84--1.00)                     0.00001
  Cross-sectional studies               51               1.08 (1.07--1.10)           1.09 (1.05--1.14)                     0.86 (0.72--0.99)                     0.00001
  Cohort+case-control studies           12               1.08 (1.03--1.13)           1.13 (0.96--1.34)                     0.91 (0.79--1.00)                     0.00001
  Full adjustment                       37               1.07 (1.06--1.09)           1.07 (1.03--1.12)                     0.86 (0.72--1.00)                     0.00001
  Incomplete adjustment                 26               1.17 (1.13--1.20)           1.15 (1.04--1.27)                     0.86 (0.74--0.97)                     0.00001
  Adults only                           13               1.17 (1.10--1.24)           1.17 (1.03--1.32)                     0.74 (0.50--0.98)                     0.00001
  Children/adolescents only             50               1.08 (1.07--1.09)           1.09 (1.04--1.14)                     0.89 (0.77--0.99)                     0.00001
  Children ISAAC method                 28               1.10 (1.09--1.12)           1.11 (1.07--1.16)                     0.84 (0.66--1.00)                     0.00001
  Children non-ISAAC method             21               0.98 (0.95--1.01)           1.06 (0.95--1.19)                     0.89 (0.78--1.00)                     0.00001
  Maternal pregnancy smoking            11               1.01 (0.96--1.06)           1.07 (0.92--1.28)                     0.83 (0.60--1.00)                     0.00001
  Quality score ≥3                      30               1.09 (1.08--1.11)           1.10 (1.04--1.15)                     0.86 (0.71--1.00)                     0.00001
  Quality score \<3                     33               1.07 (1.04--1.09)           1.10 (1.02--1.19)                     0.88 (0.78--0.98)                     0.00001

Proportion of total variance due to between-study variance.

Active Smoking {#s4b}
--------------

Using random effects analysis, there was no significant association between active smoking and the risk of allergic rhinitis when all studies are considered (RR = 1.02; 95% CI 0.92--1.15). Using fixed effect analysis for all studies, there was a significant association between active smoking and risk of rhinitis (RR = 1.06, 95% CI 1.03--1.08); however, this may be explained by the considerable amount of heterogeneity due to differences in designs, case, and exposure definitions and adjustment for confounders. It is remarkable that, under the fixed effects model, the result of the cross-sectional subgroup (RR = 1.09; 95% CI 1.06--1.12) is statistically significant and opposed to the result of the cohort studies subgroup (RR = 0.87; 95% CI 0.82--0.93).

When restricting the analysis to the ten studies carried out on children and adolescents, active smoking was associated with an increased pooled relative risk of 1.40 (95% CI 1.24--1.59). In further sub-group analyses, the association was significant in the studies that used the standardized ISAAC protocol (RR = 1.50, 95% CI 1.35--1.66), but not those that used their own protocol (RR = 0.96, 95% CI 0.88--1.08). A reverse association between active smoking and allergic rhinitis was observed in adults only (RR = 0.90, 95% CI 0.82--0.99)

Passive Smoking {#s4c}
---------------

Using random effects analysis, there was a significant association passive smoking and allergic rhinitis (RR = 1.10, 95% CI 1.06--1.15). Similar findings were observed in subgroup analyses by adjustment for confounding variables (RR = 1.07; 95% CI 1.03--1.12 for full adjustment, RR = 1.15; 95% CI 1.04--1.27 for incomplete adjustment), quality scores (RR = 1.10; 95% CI 1.04--1.15 for high quality, RR = 1.10; 95% CI 1.02--1.19 for low quality), and for cross-sectional studies (RR = 1.09; 95% CI 1.05--1.14); however, there was no significant association between passive smoking and allergic rhinitis when restricting the analysis to cohort studies (RR = 1.14; 95% CI 0.96--1.34) or case-control studies (RR = 1.14; 95% CI 0.46--2.82).

In subgroup analyses based on age group, a significant association between passive smoking and allergic rhinitis was observed in adults only (RR = 1.17; 95% CI 1.03--1.32) and in children and adolescents (RR = 1.09; 95% CI 1.04--1.14). For maternal pregnancy smoking, there was no evidence for a a significant increase in the risk of allergic rhinitis in the offspring (RR = 1.07; 95% CI 0.92--1.28).

Publication Bias {#s4d}
----------------

The funnel plot of active smoking seems to be slightly skewed to the left, which indicates a potential lack of studies that favor a positive association of the disease with smoking ([Figure 4](#pmed-1001611-g004){ref-type="fig"}). However, the Egger\'s test of asymmetry yielded a nonsignificant *p*-value of 0.27 and no hypothetical study was suggested as missing in the trim-and-fill procedure. The funnel plot for passive smoking ([Figure 5](#pmed-1001611-g005){ref-type="fig"}) and the corresponding results of the Egger\'s test did not show any evidence of publication bias (*p* = 0.53), but two new studies were imputed in the trim-and-fill procedure yielding a modified pooled relative risk of 1.10 (95% CI 1.05--1.14).

![Funnel plot of relative risk versus standard error of relative risk: allergic rhinitis, active smoking.](pmed.1001611.g004){#pmed-1001611-g004}

![Funnel plots of relative risk versus standard error of relative risk: allergic rhinitis, passive smoking.](pmed.1001611.g005){#pmed-1001611-g005}

Allergic Dermatitis {#s4e}
-------------------

We retrieved 33 studies on active smoking and 58 studies on passive smoking ([Figures 6](#pmed-1001611-g006){ref-type="fig"} and [7](#pmed-1001611-g007){ref-type="fig"}; [Tables 4](#pmed-1001611-t004){ref-type="table"} and [5](#pmed-1001611-t005){ref-type="table"}). About one-third of the studies used ISAAC criteria for case definition. Nineteen studies assessed maternal smoking during pregnancy [@pmed.1001611-Lewis1],[@pmed.1001611-Shaheen1],[@pmed.1001611-Magnusson1],[@pmed.1001611-Lee3],[@pmed.1001611-Obihara1],[@pmed.1001611-Horak1],[@pmed.1001611-Purvis1],[@pmed.1001611-Olesen1],[@pmed.1001611-Bergmann2],[@pmed.1001611-Linneberg1],[@pmed.1001611-Sariachvili1]--[@pmed.1001611-Jedrychowski1],[@pmed.1001611-Schfer1], [@pmed.1001611-Xepapadaki1], [@pmed.1001611-Civelek1], [@pmed.1001611-Apfelbacher1], [@pmed.1001611-Yi1].

![Study-specific and random effects pooled relative risks of active smoking and allergic dermatitis.](pmed.1001611.g006){#pmed-1001611-g006}

![Study-specific and random effects pooled relative risks of passive smoking and allergic dermatitis.](pmed.1001611.g007){#pmed-1001611-g007}

10.1371/journal.pmed.1001611.t004

###### Relative risks and 95% confidence intervals of dermatitis by smoking exposure in case-control and cohort studies.

![](pmed.1001611.t004){#pmed-1001611-t004-4}

  Source                                               Country         Population       Follow-up (y)   Complete Follow-up (%)    Active Smoking                      Passive Smoking                    Cases/Controls or Cohort Size                                                                            Variables of Adjustment, Matching, Restriction
  ------------------------------------------------- ------------- -------------------- --------------- ------------------------ ------------------- --------------------------------------------------- ------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Case-control studies**                                                                                                                                                                                                              
  Mills 1994 [@pmed.1001611-Mills1]                      UK              Adults              ---                 ---             1.1 (0.65--1.86)                           ---                                     127/127                                                                                                        Not specified
  Yang 2000 [@pmed.1001611-Yang1]                      Taiwan       School children          ---                 ---                    ---                          0.75 (0.46--1.25)                              144/144                                                                                Age, sex, parental education, breast feeding, parental eczema
  Purvis 2005 [@pmed.1001611-Purvis1]                New Zealand        Children             ---                 ---                    ---                                 ---                                     87/463                                                                                                              Age
  Haileamlak 2005 [@pmed.1001611-Haileamlak1]         Ethiopia          Children             ---                 ---                    ---                          1.07 (0.75--1.54)                              306/426                                                                                                             Age
  Sebok 2006 [@pmed.1001611-Sebk1]                     Hungary          Children             ---                 ---                    ---                          1.15 (0.93--1.42)                              461/343                                                                                                     Age, sex, residence
  Wang 2010 [@pmed.1001611-Wang1]                      Taiwan           Children             ---                 ---                   -----                         1.02 (0.43--2.43)                              34/106                                                                                                              Age
  Cakir 2010 [@pmed.1001611-Cakir1]                    Turkey         Adolescents            ---                 ---             1.26 (0.79--2.02)                          ---                                     436/366                                                                                      Age, sex, family atopy, pets, income, occupation
  Lee 2011 [@pmed.1001611-Lee1]                        Taiwan            Adults              ---                 ---             4.18 (1.97--8.90)                   2.22 (1.01--4.84)                              83/142                                                                                                           Age, sex
  Miyake 2011 [@pmed.1001611-Miyake4]                   Japan         Adult women            ---                 ---             1.12 (0.79--1.57)                          ---                                    188/1,082                                                                                         Age, sex, residence, siblings, education
  **Cohort studies**                                                                                                                                                                                                                    
  Burr 1989 [@pmed.1001611-Burr2]                        UK             Infants               1                  93.1                   ---                          2.03 (1.28--3.22)                              184/468                                                                                                             Age
  Zeiger 1995 [@pmed.1001611-Zeiger1]                    USA       High risk children         7                   57                    ---                           7.9 (1.0--61.0)                                9/165                                                                                  Age, sex, maternal ethnicity, parental asthma, food allergy
  Olesen 1997 [@pmed.1001611-Olesen1]                  Denmark          Children             9.5                  93                    ---                                 ---                                     184/985                                                                            Age, sex, mother\'s age at birth, parity, birth weight, family atopy
  Lewis 1998 [@pmed.1001611-Strachan1]                   UK             Children             16                   55                    ---                          1.05 (0.94--1.18)                            1,213/6,352                                                               Age, sex, social class, birth weight, gestational age, breast feeding, maternal age, parity
  Tariq 1998 [@pmed.1001611-Tariq1]                      UK             Children              4                  83.6                   ---                          0.58 (0.36--0.94)                             145/1,218                                                                                                            Age
  Shaheen 1999 [@pmed.1001611-Shaheen1]                  UK              Adults              26                  51.1            1.27(1.12--1.44)                           ---                                     ?/6,420                                                                   Age, sex, birth weight, social class, siblings, qualification, height, body mass index
  Bergmann 2000 [@pmed.1001611-Bergmann1]              Germany          Infants               6                   75                    ---                          1.21 (0.83--1.76)                              206/825                                                      Age, sex, parental atopy, socioeconomic status, breast feeding, aeroallergen and food sensitization, study centre
  McKeever 2001 [@pmed.1001611-McKeever1]                UK             Children             11                   95                    ---                          0.89 (0.87--0.92)                           8,839/29,238                                                                                            Age, sex, family atopy, siblings
  Bergmann 2002 [@pmed.1001611-Bergmann2]              Germany          Infants               7                  71.5                   ---                                 ---                                      ?/937                            Age, sex, breastfeeding duration, familial atopy, social status, allergic rhinoconjunctivitis, asthma, upper respiratory tract infections, mother\'s age, parity, IgE.
  Kerkhof 2003 [@pmed.1001611-Kerkhof1]              Netherlands        Infants               1                   ?                     ---                          1.17 (0.72--1.89)                              76/304                                             Sex, age, birth weight, gestation age, mother\'s age, breastfeeding, siblings, day-care attendance, pets, region, parental education
  Ludvigsson 2005 [@pmed.1001611-Bendtsen1]            Sweden           Infants               1                  66.5                   ---                          0.83 (0.71--0.96)                            2,038/8,784                                                                        Age, sex, pets, preterm birth, maternal education, parity, parental atopy
  Magnusson 2005 [@pmed.1001611-Magnusson1]            Denmark          Children             18                   74                    ---                           1.0 (0.8--1.1)                              1,248/7,844                                                                 Sex, social class, occupation, maternal age at pregnancy, coffee, parity, breastfeeding
  Linneberg 2006 [@pmed.1001611-Linneberg1]            Denmark          Infants              1.5                  67                    ---                                 ---                                  3,327/34,793            Age, sex, breast feeding, parental atopy, season of birth, gestation age, head circumference, birth weight, residence, maternal occupation, household income, siblings, day care attendance, pets
  Lerbaek 2007 [@pmed.1001611-Lerbaek1]                Denmark        Twin adults             9                   82             1.10 (0.87--1.40)                          ---                                    244/3,393                                                                                                       Not specified
  Noakes 2007 [@pmed.1001611-Noakes1]                 Australia         Infants               1                   67                  ^-----^        0.80 (0.28--2.24)[a](#nt104){ref-type="table-fn"}               41/82                                                                                                              Age
  Sariachvili 2007 [@pmed.1001611-Sariachvili1]        Belgium          Infants               1                   87                    ---                           1.8 (1.0--3.1)                                227/975                                               Age, sex, parental atopy, pregnancy duration, maternal educational and age, pets, antibiotics use, parity, day care attendance.
  Tanaka 2008 [@pmed.1001611-Tanaka3]                   Japan           Children              2                   76                    ---                          1.10 (0.86--1.41)                              142/763                                                                  Age, sex, birth weight, family income, parental atopy, pets, older siblings, maternal age
  Böhme 2010 [@pmed.1001611-Bhme1]                     Sweden           Children              4                  61.2                   ---                          1.68 (1.22--2.30)                             529/2,505                                                                            Age, sex, parental atopy, breastfeeding, pets, parental education.
  Jedrychowski 2011 [@pmed.1001611-Jedrychowski1]      Poland           Infants               1                  100                    ---                          1.46 (0.84--2.55)                              183/469                                                                                                             Age

Relative risk for pre- and post- natal smoking of mother.

10.1371/journal.pmed.1001611.t005

###### Relative risks and 95% confidence intervals of allergic dermatitis by smoking exposure in cross-sectional studies.

![](pmed.1001611.t005){#pmed-1001611-t005-5}

  Source                                                     Country               Population           Active Smoking        Passive Smoking      Study Size                                              Variables of Adjustment, Matching, or Restriction
  ---------------------------------------------------- ------------------- -------------------------- ------------------- ----------------------- ------------ ------------------------------------------------------------------------------------------------------------------------------------------
  Edman 1988 [@pmed.1001611-Edman1]                          Sweden                  Adults            2.37 (0.98--5.76)            ---               425                                                                    Not specified
  Bakke 1990 [@pmed.1001611-Bakke1]                          Norway          Adolescents and adults    1.12 (1.01--1.24)            ---              4,270                                                     Age, sex, occupational exposure, residence
  Volkmer 1995 [@pmed.1001611-Volkmer1]                     Australia          Preschool children             ---            0.80 (0.71--0.91)       14,124                                               Natural gas for cooking, heating and cooling sources
  Austin 1997 [@pmed.1001611-Austin1]                          UK                   Children                  ---            0.88 (0.74--1.05)       1,537                                                                        Age
  Liss 1997 [@pmed.1001611-Liss1]                            Canada                  Adults            0.86 (0.61--1.22)            ---              1,326                                                                   Not specified
  Schäfer 1997 [@pmed.1001611-Schfer1]                       Germany           Preschool children             ---                   ---               678                                                                         Age
  Duhme 1998 [@pmed.1001611-Duhme1]                          Germany             Schoolchildren        1.32 (1.07--1.62)     0.97 (0.85--1.10)       13,123                                                                     Age, sex
  Lam 1998 [@pmed.1001611-Lam1]                             Hong Kong            Schoolchildren        1.06 (0.91--1.24)     0.91 (0.80--1.03)       6,304                                                            Age, sex, residence, housing
  Montefort 1998 [@pmed.1001611-Montefort1]                   Malta              Schoolchildren        1.76 (1.47--2.12)            ---              4,184                                                   Age, sex, road, pets, parental atopy, blankets
  Farooqi 1998 [@pmed.1001611-Farooqi1]                        UK                   Children                  ---          0.97 (0.75--1.26)^\*^     1,934                                                                   Not specified
  Dotterud 1999 [@pmed.1001611-Dotterud1]                    Russia                  Adults            2.42 (1.24--4.71)            ---              3,368                                                                   Not specified
  Dotterud 2001 [@pmed.1001611-Dotterud2]                    Russia              Schoolchildren               ---            0.93 (0.78--1.11)       1,684                                                  Age, sex, carpets, dampness, pets, heating type
  Hjern 2001 [@pmed.1001611-Hjern1]                          Sweden                 Children                  ---            0.88 (0.75--1.03)       4,472                  Age, sex, siblings, parental education, residence, single parent household, country of birth of parent, location
  Lee 2001 [@pmed.1001611-Lee2]                               Korea              Schoolchildren               ---            1.09 (0.99--1.20)       38,955                                                  Age, sex, region, BMI, carpets, pets, location
  Simpson 2001 [@pmed.1001611-Simpson1]                        UK                    Adults            0.9 (0.75--1.07)             ---              5,687                                                                   Not specified
  Linneberg 2003 [@pmed.1001611-Linneberg2]                  Denmark         Adolescents and adults    2.35 (1.72--3.19)            ---              1,112                                                               Age, sex, ear piercing
  Montnemery 2003 [@pmed.1001611-Montnemery1]                Sweden                  Adults            1.03 (0.91--1.24)            ---              8,469                                                                   Not specified
  Kramer 2004 [@pmed.1001611-Krmer1]                         Germany            School beginners              ---            1.97 (1.23--3.16)       1,220                                                            Age, sex, atopy, nationality
  Demir 2004 [@pmed.1001611-Demir1]                          Turkey              Schoolchildren               ---            1.30 (0.46--3.83)        621                                                                         Age
  Annesi-Maesano 2004 [@pmed.1001611-AnnesiMaesano2]         France               Adolescents          1.39 (1.23--1.56)      0.9 (0.9--1.3)         14,578                                                                     Age, sex
  Miyake 2004 [@pmed.1001611-Miyake2]                         Japan              Schoolchildren               ---            1.04 (0.89--1.22)       5,539                          Age, sex, grade, older siblings, maternal age at child birth, pets, parental allergic diseases.
  Yemaneberhan 2004 [@pmed.1001611-Yemaneberhan1]           Ethiopia          Children and adults      1.70 (0.97--2.97)     2.13 (1.31--3.46)       12,876                                             Age, sex, socioeconomic status, residence, kerosene use
  Lee 2004 [@pmed.1001611-Lee3]                             Hong Kong            Schoolchildren               ---                 **---**            4,448                         Age, sex, birth weight, siblings, respiratory tract infections, parental atopy, pets, study period
  Heudorf 2005 [@pmed.1001611-Heudorf1]                      Germany                Children                  ---            2.34 (1.04--5.28)        287                                                                         Age
  Miyake 2005 [@pmed.1001611-Miyake3]                         Japan              Pregnant women        0.66 (0.43--1.02)     1.08 (0.81--1.44)       1,002                          Age, sex, familial atopy, pets, gestation, parity, family income, education, mite antigen level
  Montnemery 2005 [@pmed.1001611-Montnemery2]                Sweden                  Adults            1.35 (1.04--1.75)            ---              6,109                                                                   Not specified
  Obihara 2005 [@pmed.1001611-Obihara1]                   South Africa              Children                  ---                   ---               861                                Age, sex, maternal atopy, breast feeding, siblings, household income, tuberculin test
  Kurosaka 2006 [@pmed.1001611-Kurosaka1]                     Japan              Schoolchildren               ---            0.99 (0.93--1.05)       35,242                                                                       Age
  Sakar 2006 [@pmed.1001611-Sakar1]                          Turkey                  Adults            1.31 (0.97--1.78)            ---              1,336                                                                   Not specified
  Dotterud 2007 [@pmed.1001611-Dotterud3]                    Norway                  Adults            1.20 (0.89--1.60)            ---              1,236                                                  Age, sex, atopic dermatitis, rhinitis and asthma
  Horak 2007 [@pmed.1001611-Horak1]                          Austria           Preschool children             ---            1.06 (0.76--1.48)       1,737                                  Age, sex, familial atopy, education, family size, pets, breastfeeding, nutrition
  Tanaka 2007 [@pmed.1001611-Tanaka1]                         Japan                 Children                  ---            1.08 (1.02--1.14)       23,044                                          Age, sex, location, familial atopy, siblings, education level
  Zuraimi 2008 [@pmed.1001611-Zuraimi1]                     Singapore          Preschool children             ---            1.02 (0.95--1.09)       4,759            Age, familial atopy, race, socioeconomic status, housing type, breastfeeding, food allergy, respiratory infections, dampness
  Al-Sahab 2008 [@pmed.1001611-AlSahab1]                     Lebanon              Adolescents                 ---            1.46 (1.11--1.94)       2,893                                                   Age, sex, exercise, traffic, asthma, rhinitis
  Ergin 2008 [@pmed.1001611-Ergin1]                          Turkey              Schoolchildren               ---            1.30 (0.89--1.91)       1,644                                                                        Age
  Foliaki 2008 [@pmed.1001611-Foliaki1]                 Pacific countries           Children                  ---            1.20 (1.11--1.30)       20,876                                                               Age, sex and country
  Suárez-Varela 2008 [@pmed.1001611-SurezVarela1]             Spain              Schoolchildren               ---            1.03 (0.99--1.06)       59,040                                            Age, sex, asthma, rhinitis, siblings, mother\'s education
  Attwa 2009 [@pmed.1001611-Attwa1]                           Egypt                Adult men           3.59 (1.0--13.5)             ---               163                                                                         Sex
  Meding 2009 [@pmed.1001611-Meding1]                        Sweden                  Adults            1.05 (0.95--1.16)            ---              13,452                                                            Age, sex, history of atopy
  Brescianini 2009 [@pmed.1001611-Brescianini1]               Italy              Schoolchildren               ---            1.22 (0.77--1.95)        481                                         Age, sex, family atopy, BMI, pets, physical activity, diet, location
  Musharrafieh 2009 [@pmed.1001611-Musharrafieh1]            Lebanon              Adolescents                 ---             1.1 (0.9--1.4)         3,115                                       Age, sex, nationality, regions, school type, traffic, asthma, rhinitis
  Kabir 2009 [@pmed.1001611-Kabir1]                          Ireland                Children                  ---            1.24 (0.90--1.70)       2,809                                                                      Age, sex
  Lipinska 2009 [@pmed.1001611-Lipiska1]                     Poland                 Children                  ---           3.40 (1.19--11.86)        283                                                                    Not specified
  Xepapadaki 2009 [@pmed.1001611-Xepapadaki1]                Greece            Preschool children             ---            0.98 (0.79--1.22)       2,374                                                                      Age, sex
  Wang 2010 [@pmed.1001611-Wang2]                            Canada              Schoolchildren               ---            1.05 (0.79--1.41)       8,334                Age, sex, BMI, location, birthplace, ethnicity, maternal education, siblings, pets, acetaminophen, physical activity
  Röhrl 2010 [@pmed.1001611-Rhrl1]                           Sweden               Adolescents                 ---            0.85 (0.59--1.23)       6,095                                                    Age, sex, flexural eczema and nickel allergy
  Thyssen 2010 [@pmed.1001611-Thyssen1]                      Denmark                 Adults            1.28 (1.10--1.49)            ---              3,471                                                  Age, sex, alcohol consumption, educational level
  Meding 2010 [@pmed.1001611-Meding2]                        Sweden                  Adults            1.15 (1.08--1.22)            ---              25,428                                                            Age, sex, history of atopy
  Yang 2011 [@pmed.1001611-Yang2]                              USA                   Adults            0.88 (0.71--1.10)     1.21 (0.85--1.74)       2,974                                                                   Not specified
  Vlaski 2011 [@pmed.1001611-Vlaski1]                       Macedonia             Adolescents                 ---            0.93 (0.80--1.09)       3,026                                       Age, sex, diet, source of heating, pets, maternal education, siblings
  Civelek 2011 [@pmed.1001611-Civelek1]                      Turkey              Schoolchildren               ---            1.35 (1.17--1.56)       6,755                                                                        Age
  Dei-Cas 2011 [@pmed.1001611-DeiCas1]                      Argentina               Children                  ---            1.45 (1.02--2.08)        722                                                                         Age
  Apfelbacher 2011 [@pmed.1001611-Apfelbacher1]              Germany        Children and adolescents          ---            0.90 (0.77--1.04)       17,270     Age, sex, socioeconomic status, migrant status, siblings, breastfeeding, mother\'s alcohol consumption, pets, infection, parental atopy.
  Park 2011 [@pmed.1001611-Park1]                             Korea                  Adults            1.69 (1.27--2.24)            ---              1,990                                            Age, sex, BMI, education, income, alcohol, fish consumption.
  Berglind 2011 [@pmed.1001611-Berglind1]                    Sweden                  Adults            1.03 (1.01--1.04)            ---              27,793                       Neck and shoulder pain, depression, well-being, job strain, low back pain, physical activity at work
  Breunig 2012 [@pmed.1001611-Breunig1]                      Brazil             Male adolescents       1.06 (0.75--1.50)            ---              2,201                                         Age, sex, white race, socioeconomic level, triceps skin fold, acne
  Yi 2012 [@pmed.1001611-Yi1]                                 Korea                 Children                  ---            1.30 (1.23--1.38)       6,372                                    Age, sex, residence, income, parental education, atopy, IgE level, rhinitis
  Rönmark 2012 [@pmed.1001611-Rnmark1]                       Sweden                  Adults            1.20 (1.16--1.25)            ---              18,087                                    Age, sex, family history of atopy, exposure to gas, dust or fumes at work
  Tanaka 2012 [@pmed.1001611-Tanaka2]                         Japan              Pregnant women        1.08 (0.85--1.37)     1.42 (0.99--2.05)       1,743                                          Age, sex, region of residence; parental atopy, income, education
  Montefort 2012 [@pmed.1001611-Montefort2]                   Malta                 Children           1.68 (1.35--2.09)     1.24 (1.13--1.37)       7,955                                                                        Age
  Mitchell 2012 [@pmed.1001611-Mitchell1]                   Worldwide               Children                  ---            1.11 (1.09--1.14)      573,061                                                Age, sex, language, region, gross national income

10.1371/journal.pmed.1001611.t006

###### Pooled relative risks and 95% confidence intervals of allergic dermatitis and smoking.

![](pmed.1001611.t006){#pmed-1001611-t006-6}

  Study Type                     Number of Studies   RR (95% CI) Fixed Effects   RR (95% CI) Random Effects   Ri[a](#nt105){ref-type="table-fn"} (95% CI)   Q test (*p*-Value)
  ----------------------------- ------------------- --------------------------- ---------------------------- --------------------------------------------- --------------------
  **Active smoking**                                                                                                                                       
  All studies                           33               1.05 (1.04--1.06)           1.21 (1.14--1.29)                     0.96 (0.91--1.00)                     0.00001
  Cohort studies                         2               1.23 (1.10--1.38)           1.23 (1.09--1.38)                     0.10 (0.00--1.00)                      0.3003
  Case-control studies                   4               1.30 (1.03--1.64)           1.47 (0.92--2.32)                     0.73 (0.27--1.00)                      0.0160
  Cross-sectional studies               27               1.05 (1.04--1.06)           1.21 (1.13--1.30)                     0.97 (0.92--1.00)                     0.00001
  Cohort+case-control studies            6               1.24 (1.13--1.38)           1.27 (1.04--1.56)                     0.67 (0.11--1.00)                      0.0412
  Full adjustment                       17               1.05 (1.04--1.06)           1.21 (1.12--1.31)                     0.98 (0.93--1.00)                     0.00001
  Incomplete adjustment                 16               1.21 (1.14--1.29)           1.25 (1.09--1.45)                     0.77 (0.56--0.98)                     0.00001
  Adults only                           23               1.04 (1.03--1.05)           1.14 (1.07--1.22)                     0.96 (0.89--1.00)                     0.00001
  Children/adolescents only              7               1.36 (1.27--1.46)           1.36 (1.17--1.46)                     0.76 (0.44--1.00)                      0.0008
  Quality score ≥3                      17               1.18 (1.13--1.23)           1.22 (1.11--1.34)                     0.78 (0.55--1.00)                     0.00001
  Quality score \<3                     16               1.04 (1.03--1.05)           1.22 (1.11--1.34)                     0.98 (0.94--1.00)                     0.00001
  **Passive Smoking**                                                                                                                                      
  All studies                           58               1.04 (1.03--1.06)           1.07 (1.03--1.12)                     0.84 (0.71--0.98)                     0.00001
  Cohort studies                        14               0.92 (0.90--0.95)           1.09 (0.96--1.23)                     0.89 (0.72--1.00)                     0.00001
  Case-control studies                   5               1.11 (0.94--1.31)           1.10 (0.88--1.38)                     0.34 (0.00--1.00)                      0.2411
  Cross-sectional studies               39               1.08 (1.06--1.09)           1.07 (1.02--1.12)                     0.81 (0.63--0.99)                     0.00001
  Cohort+case-control studies           19               0.93 (0.90--0.95)           1.09 (0.98--1.21)                     0.86 (0.66--1.00)                     0.00001
  Full adjustment                       32               1.08 (1.07--1.10)           1.08 (1.03--1.13)                     0.81 (0.60--1.00)                     0.00001
  Incomplete adjustment                 26               0.96 (0.94--0.98)           1.06 (0.98--1.14)                     0.84 (0.65--1.00)                     0.00001
  Adults only                            4               1.24 (1.03--1.50)           1.26 (1.02--1.55)                     0.17 (0.00--1.00)                       0.31
  Children/adolescents only             53               1.04 (1.03--1.05)           1.06 (1.01--1.11)                     0.85 (0.72--0.98)                     0.00001
  Children ISAAC method                 22               1.07 (1.06--1.09)           1.09 (1.04--1.14)                     0.73 (0.41--1.00)                     0.00001
  Children non-ISAAC method             29               0.99 (0.97--1.01)           1.05 (0.97--1.15)                     0.89 (0.77--1.00)                     0.00001
  Maternal pregnancy smoking            19               0.99 (0.95--1.03)           1.07 (0.96--1.19)                     0.80 (0.62--0.98)                     0.00001
  Quality score ≥3                      28               1.04 (1.02--1.05)           1.11 (1.05--1.18)                     0.88 (0.74--1.00)                     0.00001
  Quality score \<3                     30               1.06 (1.03--1.09)           1.03 (0.96--1.11)                     0.80 (0.63--0.98)                     0.00001

Proportion of total variance due to between-study variance.

Active Smoking {#s4f}
--------------

Using random effects analysis, active smoking was significantly associated with an increased risk of allergic dermatitis overall (RR = 1.21; 95% CI 1.14--1.29) and in both adults (RR = 1.14; 95% CI 1.07--1.22) and in children and adolescents (RR = 1.36; 95% CI 1.17--1.46)

In sub-group analyses, the association between active smoking and allergic dermatitis was similar based on age, adjustment for confounding, quality scores, and for cohort studies and cross-sectional studies, although there was no significant association between active smoking and allergic dermatitis observed in the four case-control studies (RR = 1.47; 95% CI 0.92--2.32).

Passive Smoking {#s4g}
---------------

Using random effects analysis, passive smoking was associated with an increased risk of allergic dermatitis in the general population (RR = 1.07; 95% CI 1.03--1.12).

In sub-group analyses, the association between passive smoking and allergic dermatitis was significant when restricted to cross-sectional studies (RR = 1.07; 95% CI 1.02--1.12), but not for cohort (RR = 1.09; 95% CI 0.96--1.23) or case-control studies (RR = 1.10; 95% CI 0.88--1.38). A significant association between passive smoking and allergic dermatitis was observed for those studies with adjustment for confounding variables (RR = 1.08; 95% CI 1.03--1.13) and higher quality scores (RR = 1.11; 95% CI 1.05--1.18), but not those without adjustment (RR = 1.06; 95% CI 0.98--1.14) or low quality scores (RR = 1.03; 95% CI 0.96--1.11).

A significant association was observed in those studies including adults only (RR = 1.26; 95% CI 1.02--1.55) and in those including children and adolescents only (RR = 1.06; 95% CI 1.01--1.11). No significant association was observed between maternal smoking and allergic dermatitis (RR = 1.07; 95% CI 0.96--1.19).

Publication Bias {#s4h}
----------------

The Egger\'s test for asymmetry of the funnel plot of active smoking ([Figure 8](#pmed-1001611-g008){ref-type="fig"}) yielded a *p*-value of 0.28 and no study was added in the trim-and-fill procedure. No asymmetry was detected for passive smoking ([Figure 9](#pmed-1001611-g009){ref-type="fig"}) through the Egger\'s test (*p* = 0.33) but the trim-and-fill procedure suggested that ten potential studies were missing. The modified random effects pooled relative risk was 1.04 (95% CI 1.00--1.08).

![Funnel plots of relative risk versus standard error of relative risk: allergic dermatitis, active smoking.](pmed.1001611.g008){#pmed-1001611-g008}

![Funnel plot of relative risk versus standard error of relative risk: allergic dermatitis, passive smoking.](pmed.1001611.g009){#pmed-1001611-g009}

Food Allergies {#s4i}
--------------

We retrieved only one study for active smoking and six studies for passive smoking, while three studies assessed maternal smoking during pregnancy ([Figure 10](#pmed-1001611-g010){ref-type="fig"}; [Table 7](#pmed-1001611-t007){ref-type="table"}). All were carried out in children or infants populations.

![Study-specific and random effects pooled relative risks of passive smoking and food allergies.](pmed.1001611.g010){#pmed-1001611-g010}

10.1371/journal.pmed.1001611.t007

###### Study-specific and 95% confidence intervals of food allergies and smoking.
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  Author                                         Country    Population   Follow-up (y)   Complete Follow-up (%)    Active Smoking      Passive Smoking    Maternal Pregnancy Smoking   Cases/Controls or Cohort Size or Total Sample Size                                   Variables of Adjustment, Matching, or Restriction
  -------------------------------------------- ----------- ------------ --------------- ------------------------ ------------------- ------------------- ---------------------------- ---------------------------------------------------- -------------------------------------------------------------------------------------------------------------------
  **Case-control studies**                                                                                                                                                                                                                 
  Metsälä 2010 [@pmed.1001611-Metsl1]            Finland     Infants          ---                 ---                    ---                 ---              0.72 (0.67--0.79)                          16,237/16,237                             Age, multiple pregnancy, gestational age, ponderal index, socioeconomic status, previous deliveries
  Kavaliunas 2011 [@pmed.1001611-Kavalinas1]    Lithuania    Children         ---                 ---                    ---                 ---              2.69 (0.63--13.89)                             42/144                                                                                Age
  **Cohort studies**                                                                                                                                                                                                                       
  Zeiger 1995 [@pmed.1001611-Zeiger1]              USA       Children          7                   57                    ---          0.92 (0.20--3.70)              ---                                     22/165                                                                                Age
  Tariq 1998 [@pmed.1001611-Tariq1]                UK        Children          4                  83.6                   ---          0.76 (0.30--1.86)              ---                                    34/1,280                                                                               Age
  Kulig 1999 [@pmed.1001611-Kulig1]              Germany     Children          3                   ?                     ---          1.56 (0.97--2.48)              ---                                     ?/328                                                                Age, parental education, study center
  Noakes 2007 [@pmed.1001611-Jedrychowski1]     Australia    Infants           1                  67.2                   ---          0.78 (0.24--2.43)              ---                                     25/82                                                                                 Age
  Lannerö 2008 [@pmed.1001611-Lanner1]           Sweden      Children          4                   62                    ---          1.61 (1.16--2.24)       1.28 (0.72--2.26)                            331/2,529                                                            Age, parental atopy, socioeconomic status
  **Cross-sectional studies**                                                                                                                                                                                                              
  Hjern 2001 [@pmed.1001611-Hjern1]              Sweden      Children         ---                 ---                    ---          0.93 (0.77--1.11)              ---                                     4,472                          Age, sex, siblings, parental education, residence, single parent household, country of birth of parents, location
  Dubakiene 2008 [@pmed.1001611-Dubakien1]      Lithuania    Children         ---                 ---             0.58 (0.21--1.55)          ---                     ---                                      540                                                                             Not specified

Active Smoking {#s4j}
--------------

The only available study on active smoking and food allergies did not show any significant association (RR = 0.58; 95% CI 0.21--1.55).

Passive Smoking {#s4k}
---------------

Using random effect analysis, including the six studies investigating exposure to secondhand smoke, showed that passive smoking was associated with a nonsignificant increase of the risk of food allergy (RR = 1.16; 95% CI 0.85--1.59). When the only cross-sectional study was excluded and the analysis was based on five cohort studies, passive smoking was significantly associated with an increased risk of food allergy (RR = 1.43; 95% CI 1.12--1.83) ([Table 8](#pmed-1001611-t008){ref-type="table"}). As with allergic rhinitis and allergic dermatitis, we could not detect any association with maternal smoking during pregnancy with food allergies (RR = 1.01; 95% CI 0.56--1.82) ([Table 8](#pmed-1001611-t008){ref-type="table"}).

10.1371/journal.pmed.1001611.t008

###### Pooled relative risks and 95% confidence intervals of food allergies and smoking.
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  Pooled Results                                          Passive SmokingAll Studies   Passive SmokingCohort Studies   Maternal Pregnancy Smoking
  ------------------------------------------------------ ---------------------------- ------------------------------- ----------------------------
  ***n*** **studies**                                                 6                              5                             3
  **RR (95% CI), fixed effects**                              1.08 (0.93--1.24)              1.43 (1.12--1.83)             0.73 (0.67--0.80)
  **RR (95% CI), random effects**                             1.16 (0.85--1.59)              1.43 (1.11--1.83)             1.01 (0.56--1.82)
  **Ri** [a](#nt106){ref-type="table-fn"} **(95% CI)**        0.68 (0.13--1.00)              0.01 (0.00--1.00)             0.96 (0.84--1.00)
  **Q Test (** ***p-*** **value)**                                  0.0386                        0.4026                         0.0440

Proportion of total variance due to between-study variance.

Publication Bias {#s4l}
----------------

The funnel plot ([Figure 11](#pmed-1001611-g011){ref-type="fig"}), although not a valuable way to assess publication bias in this case due to the small sample size, did not provide evidence of asymmetry (*p* = 0.09).

![Funnel plot of relative risk versus standard error of relative risk: food allergy, passive smoking.](pmed.1001611.g011){#pmed-1001611-g011}

Meta-regression {#s4m}
---------------

The meta-regression with the pooled log relative risk as a dependent variable and the population variable as a moderator, introduced in the model as a dichotomous variable (adults/pediatric population), yielded the following results for the children and adolescents when compared to the adults: allergic rhinitis and active smoking: RR = 1.55, 95% CI 1.30--1.84; allergic rhinitis and passive smoking: RR = 0.93, 95% CI 0.81--1.06; allergic dermatitis and active smoking: RR = 1.18, 95% CI 1.01--1.39; and allergic dermatitis and passive smoking: RR = 0.83, 95% CI 0.65--1.06. These results suggest that the associations between allergic rhinitis and allergic dermatitis with active smoking are significantly greater among children and adolescents than among adults. Although these meta-regression RRs were not statistically significant at a 95% level for passive smoking, in [Tables 3](#pmed-1001611-t003){ref-type="table"} and [6](#pmed-1001611-t006){ref-type="table"} we present the results of children and adolescent populations as a subgroup both for active and passive smoking.

Sub-group Analyses in Children and Adolescents {#s4n}
----------------------------------------------

We calculated the random effects pooled relative risks for children cohort studies, then for children cohort studies and case-control studies combined. For cohort studies, passive smoking was not significantly associated with allergic rhinitis (RR = 1.14; 95% CI 0.96--1.34, nine studies), or allergic dermatitis (RR = 1.09; 95% CI 0.96--1.23, 14 studies), but was significantly associated with an increased risk of food allergy (RR = 1.43; 95% CI 1.11--0.83, five studies). For cohort and case-control studies combined, passive smoking was significantly associated with an increased risk for allergic rhinitis: RR = 1.17 (95% CI 1.00--1.38, ten studies), but not for allergic dermatitis: RR = 1.07 (95% CI 0.96--1.19, 18 studies).

Sensitivity Analysis {#s4o}
--------------------

To further evaluate the possibility that the results obtained for children/adolescents were due to publication bias, we assumed that cross-sectional studies are the kind of studies that are most probably rejected by journals in case of null results and recalculated our pooled estimates under the following extreme assumptions: (1) published cross-sectional studies are only half of the studies of smoking and allergic rhinitis ever conducted among children, (2) all unpublished studies found an RR of 1, (3) the unpublished studies found the same prevalence of allergic diseases as the average of the published studies. Under these extreme assumptions, the random effects pooled estimates for active smoking still show a significant increase in risk: RR = 1.16 (95% CI 1.08--1.25) for allergic rhinitis and RR = 1.13 (95% CI 1.05--1.21) for allergic dermatitis.

Discussion {#s5}
==========

The results of our systematic review and meta-analysis suggest that active and passive smoking are associated with a modest increase in risk for some allergic diseases. In the overall population, active smoking was associated with a modest increase in the risk for allergic dermatitis but not allergic rhinitis, while passive smoking was associated with modest increases in the risks for both allergic dermatitis and allergic rhinitis. Among children and adolescents, we observed significant associations between both active and passive smoking and allergic rhinitis and allergic dermatitis, and passive smoking was associated with an increased risk for food allergy

In children and adolescents, while the observed increase in risk for allergic diseases associated with smoking was small, the findings are important given that to the prevalence of active and passive smoking in this population can be high. Worldwide, 14% of adolescents aged 13 to 15 are active smokers with some countries reaching a prevalence of 40%, and nearly 25% of the children who smoke have smoked their first cigarette before the age of 10 years [@pmed.1001611-The1]. Furthermore, in the US, more than one-third of children live with at least one adult smoker [@pmed.1001611-King1]. In other parts of the world, passive exposure to tobacco among children is even higher as nearly half of children were exposed to tobacco smoke at home [@pmed.1001611-Centers1]. On the basis of the figures above, in countries with high smoking prevalence we estimate that 14% of allergic rhinitis and 13% of allergic dermatitis are attributable to active smoking [@pmed.1001611-Rothman2]. Eliminating active smoking in children and adolescents would then prevent one in every seven cases of allergic rhinitis and one in every eight cases of allergic dermatitis.

That age is an important effect modifier for the relation between tobacco exposure and risk of allergic diseases is biologically plausible. The US Surgeon General has suggested that the immaturity of the respiratory, nervous, and immune systems in children may make them vulnerable to health effects of smoking [@pmed.1001611-US1]. Furthermore, unlike adults, children have limited options for avoiding exposure to secondhand smoke and are unable to reduce the quantity of products inhaled [@pmed.1001611-US1].

Our finding that maternal exposure is not associated with the risk of allergic diseases in the offspring confirms the results from a previous meta-analysis that focused on the risk of allergic sensitization measured through skin prick positivity or IgE concentrations [@pmed.1001611-Strachan1]. It is possible that the lack of observed association is due to the existence of bias given that parents of children at high risk of allergy may selectively avoid smoking during pregnancy.

The findings from our meta-analysis are subject to several limitations. The majority of studies were cross-sectional, a design that does not allow for causal inference and can overestimate relative risks given its reliance on prevalence ratios. When restricted to cohort studies our analyses showed that many of the results were no longer significant, especially for the subgroup analysis in children and adolescents. There is then some evidence that the findings may be impacted by study design.

Residual confounding (confounding remaining after adjustment) may explain some of our findings. For some of our analyses, we were unable to detect meaningful differences in the results between studies that had incomplete adjustment for confounders and those with more complete adjustment for confounders and our findings were broadly similar when restricting the analyses to studies with higher quality scores. However, there are likely to be other factors, such as genetic factors that were not controlled for and may play a role in the relationship between smoking and allergic diseases. Although publication bias cannot be ruled out, its magnitude is likely to be low as shown by the robustness of our sensitivity analysis.

Several studies assessed allergic diseases through self-report only, which can lead to misclassification of allergic and non-allergic conditions. Similarly, the findings are limited by measurement error in the smoking exposure given that a majority of studies assessed exposure to smoking in a qualitative fashion and often on a yes/no basis instead of using a quantitative assessment. Misclassification and measurement error in SHS assessment may result from a respondent\'s lack of knowledge about current or past exposure, biased recall, whether intentional or unintentional, and the difficulty in characterizing an exposure in complex indoor environments [@pmed.1001611-US2]. A standard set of items to identify passive smoking in distinct settings is needed [@pmed.1001611-PrezRos1]. If misclassification exists, it is probable that the outcome misclassification is not differential in regard to smoking and, similarly, measurement error in smoking assessment is not differential in regard to diagnosis. In this case, the results would be biased towards the null value, which means that the association with smoking observed in our meta-analysis is underestimated.

In our subgroup analyses, we were unable to identify any factors that accounted for study heterogeneity. Given the high heterogeneity estimates, we focused our interpretation on the random effects estimates. The random effects model gives increased weights to the effect of small studies, which may introduce bias in the estimation. It is worth noting that for some of the analyses, the fixed effects and random effects estimates differ substantially; this may be due to differences in case or exposure definition and in adjustment for potential confounders.

Our subgroup analyses found stronger evidence for associations between smoking and allergic diseases in children and adolescents than adults. Furthermore, our meta-regression suggested that the association between active smoking and allergic disorders is larger in children and adolescents than in adults, which advocates for a transient effect through life. This finding is in accordance with the "atopic march" concept that suggests that the sequence of sensitization that starts in childhood may show a tendency to spontaneous remission later in life [@pmed.1001611-Wahn1]. It is then plausible that sensitization to tobacco is mitigated by increasing age. Further research is needed to verify whether the association between smoking and risk of allergy in adults is similar for those who started smoking as an adult and those who started smoking during childhood or adolescents.

Future studies should minimize measurement error in the exposure and misclassification bias in the outcome. These studies should avoid cross-sectional designs, use extensive validated questionnaires in order to assess smoking in a quantitative fashion, and should be based on an optimal diagnosis of allergic diseases.
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======================
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AS

:   active smoking

IgE

:   immunoglobulin-E

ISAAC

:   International Study of Asthma and Allergies in Childhood

OR

:   odds ratio

RR

:   relative risk

SHS

:   secondhand smoke

SPT

:   skin prick test
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